Senolytic Therapies
July 16, 2019 | Terry Sharrer
“In mice, the selective elimination of SNCs (senescent cells, senolysis) extends median life span and prevents or attenuates age-associated diseases. This has inspired the development of targeted senolytic drugs to eliminate the SNCs that drive age-associated disease in humans.” MORE
Image Credit: Mayo Clinic News Network